T Cell News and Research

Latest T Cell News and Research

UC Davis Health evaluates new antibody cocktail as a possible treatment for COVID-19

Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.

20 Jul 2020

Mutant zebrafish opens a window into evolutionary history of human spine

A chance mutation that led to spinal defects in a zebrafish has opened a little window into our own fishy past.

20 Jul 2020

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

A phase 2 trial of an Ad5 vectored COVID-19 vaccine candidate, conducted in China, has found that the vaccine is safe and induces an immune response, according to new research published in The Lancet.

20 Jul 2020

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Promising early stage results from a phase 1/2 clinical trial of the UK's vaccine candidate against SARS-CoV-2 (the virus that causes COVID-19) are published today in The Lancet.

20 Jul 2020

Experimental therapy slows zika replication and prevents microcephaly in mice

An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor), a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation, enables the immune system to combat replication of zika virus in the organism far more effectively.

20 Jul 2020

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics spin-off, the aim of which is to develop new immuno-oncological therapeutic tools with various preclinical candidates, based on CAR-T technology for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), a rare subtype of leukemia that mainly affects children, and which has a poor prognosis.

20 Jul 2020

How immune cells switch to attack mode

Unraveling a key motif: The T lymphocytes of the immune system work to destroy infected cells or cancer cells. To do so, they have to identify the threat: Molecules perceived as foreign - so-called antigens - bind to the T-cell receptor on the T cell surface.

20 Jul 2020

Researchers develop new nano drug that kills triple-negative breast cancer cells

Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.

20 Jul 2020

Study identifies toxicological risks of environmental pollutants in finless porpoises

A recent study just published in Environmental Science & Technology identified the toxicological risks of environmental pollutants to finless porpoises (Neophocaena asiaeorientalis).

20 Jul 2020

An ickier outbreak: Trench fever spread by lice is found in Denver

Dr. Michelle Barron, medical director of infection prevention and control at UCHealth University of Colorado Hospital, received an unusual call last month from the microbiology lab: confirmation of the third case this year of trench fever, a rare condition transmitted by body lice that plagued soldiers during World War I.

20 Jul 2020

HORIBA Medical launches digital blood cell morphology QC, training and evaluation tool

HORIBA UK Ltd, Medical announces that it has launched an affordable digital tool for online skill evaluation and training in cytology.

20 Jul 2020

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK’s innovation agency.

From Fluidic Sciences and Sphere Bio 20 Jul 2020

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

The coronavirus pandemic is still rapidly spreading across the globe, infecting more than 14.44 million people. With more than 188 countries and territories affected, scientists are racing to develop a vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19).

19 Jul 2020

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

The drug Hydroxychloroquine has long been studied as a treatment for malaria and autoimmune diseases. When the coronavirus pandemic spread across the globe, many countries resorted to using the drug in the hopes that it would improve outcomes of hospitalized patients affected by the coronavirus disease (COVID-19).

19 Jul 2020

Researchers are producing COVID-19 spike proteins to prevent future infections

On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.

19 Jul 2020

MU offers an alternative to chemotherapy for treatment of cancer in animals and humans

Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.

19 Jul 2020

Perspective: T cell reaction to SARS-CoV-2 virus is a crucial target for research

While early research on the adaptive immune response to COVID-19 primarily looked at antibodies, more information is now emerging on how T cells react to the SARS-CoV-2 virus - addressing a crucial knowledge gap, say Daniel Altmann and Rosemary Boyton in a new Perspective.

17 Jul 2020

SARS-CoV-2 protein effectively shuts down production of proteins in the host, study shows

A detailed study of a SARS-Cov-2 protein, Nsp1, with a central role in weakening the host anti-viral immune response shows that it effectively shuts down production ofproteins in the host.

17 Jul 2020

Study reveals intricate details about the biology of huntingtin protein

A new study reveals intricate details about the biology of the huntingtin protein (HTT), which is responsible for Huntington's disease.

17 Jul 2020

Fox Chase and BGU receive grant for cancer treatment study

Scientists at Fox Chase Cancer Center and Ben-Gurion University of the Negev (BGU) have received a new grant from the United States-Israel Binational Science Foundation (BSF) that will fund continuing research on an antibody developed as part of a longstanding collaboration between the two organizations.

17 Jul 2020

T Cell News and Research

Latest T Cell News and Research

UC Davis Health evaluates new antibody cocktail as a possible treatment for COVID-19

Mutant zebrafish opens a window into evolutionary history of human spine

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Experimental therapy slows zika replication and prevents microcephaly in mice

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

How immune cells switch to attack mode

Researchers develop new nano drug that kills triple-negative breast cancer cells

Study identifies toxicological risks of environmental pollutants in finless porpoises

An ickier outbreak: Trench fever spread by lice is found in Denver

HORIBA Medical launches digital blood cell morphology QC, training and evaluation tool

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

Researchers are producing COVID-19 spike proteins to prevent future infections

MU offers an alternative to chemotherapy for treatment of cancer in animals and humans

Perspective: T cell reaction to SARS-CoV-2 virus is a crucial target for research

SARS-CoV-2 protein effectively shuts down production of proteins in the host, study shows

Study reveals intricate details about the biology of huntingtin protein

Fox Chase and BGU receive grant for cancer treatment study

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in